Promote Sponsor
verified SJR 0,501 · Q3 • database Scopus / SJR & Web of Science indexed
Future Medicinal Chemistry
United Kingdom · Taylor and Francis Ltd.
workspace_premium Q3 — Drug Discovery lock Subscription Unclaimed

Future Medicinal Chemistry

Future Medicinal Chemistry is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 98. It has a price of 2417 €. It has an SJR impact factor of 0,501 and it has a best quartile of Q3. It has an SJR impact factor of 0,501.

Future Medicinal Chemistry focuses its scope in these topics and keywords: synthesis, agents, therapeutic, discovery, inhibitors, drug, exploitation, improve, activity, developments, ...

ISSN: 1756-8919
Editorial: Taylor and Francis Ltd.
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD
schedule Datos CoP · solo campos en BD
SJR Impact Factor trending_up
0,501 Q3
H-index 98
Tasa de Aceptación pie_chart
27% Selectiva
Fuente Acceptance_Rate
Tiempo a publicación hourglass_top
NPD
Campo Sin dato
Coste de Publicación (APC) payments
2.417 € Subscription
Ruta Non-OA 0 €

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

0,501

H-index

98

Docs (year)

175

Docs 3y

446

Total refs

10018

Cites 3y

1296

Citable 3y

399

Cites/Doc 2y

2.7

Ref/Doc

57.25

Immediate OA

2417 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQS